Early kinetics of C-reactive protein predicts oncological outcome of patients with metastatic renal cell carcinoma under first-line therapy with immune checkpoint inhibitors

被引：0
|
作者：
Schuettke, V [1 ]
Kusiek, C. [1 ]
Mehralivand, S. [1 ]
Buerk, B. T. [1 ]
Thomas, C. [1 ]
Fuessel, S. [1 ]
Erdmann, K. [1 ]
机构：
[1] Tech Univ Dresden, Dept Urol, Dresden, Germany
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A1031
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Axitinib as first-line therapy in metastatic renal cell carcinoma
    Nozawa, Masahiro
    Uemura, Hirotsugu
    TRANSLATIONAL CANCER RESEARCH, 2014, 3 (06) : 555 - 557
  • [22] Tolerability of first-line therapy for metastatic renal cell carcinoma
    Porta, Camillo
    Szczylik, Cezary
    CANCER TREATMENT REVIEWS, 2009, 35 (03) : 297 - 307
  • [23] Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
    Yosuke Yasuda
    Kazutaka Saito
    Takeshi Yuasa
    Sho Uehara
    Naoko Kawamura
    Minato Yokoyama
    Junichiro Ishioka
    Yoh Matsuoka
    Shinya Yamamoto
    Tetsuo Okuno
    Junji Yonese
    Kazunori Kihara
    Yasuhisa Fujii
    International Journal of Clinical Oncology, 2017, 22 : 1081 - 1086
  • [24] Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
    Yasuda, Yosuke
    Saito, Kazutaka
    Yuasa, Takeshi
    Uehara, Sho
    Kawamura, Naoko
    Yokoyama, Minato
    Ishioka, Junichiro
    Matsuoka, Yoh
    Yamamoto, Shinya
    Okuno, Tetsuo
    Yonese, Junji
    Kihara, Kazunori
    Fujii, Yasuhisa
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (06) : 1081 - 1086
  • [25] First-line immune checkpoint inhibitors for patients with metastatic urothelial carcinoma treated in routine clinical practice
    Naito, Renato
    Izumi, Kouji
    Mizokami, Atsushi
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 986 - 990
  • [26] C-reactive protein flare-response predicts long-term efficacy to first-line anti-PD-1-based combination therapy in metastatic renal cell carcinoma
    Klumper, Niklas
    Schmucker, Philipp
    Hahn, Oliver
    Hoh, Benedikt
    Mattigk, Angelika
    Banek, Severine
    Ellinger, Jorg
    Heinzelbecker, Julia
    Sikic, Danijel
    Eckstein, Markus
    Strauss, Arne
    Zengerling, Friedemann
    Holzel, Michael
    Zeuschner, Philip
    Kalogirou, Charis
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (12)
  • [27] Correction to: Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor
    Moshe C. Ornstein
    Laura S. Wood
    Advances in Therapy, 2023, 40 : 4116 - 4116
  • [28] Early C-reactive Protein Kinetics Predict Response to Immune Checkpoint Blockade in Unresectable Hepatocellular Carcinoma
    Qin, Qiuying
    Kou, Xiaoxuan
    Zheng, Yuanyuan
    Zhou, Fei
    Zhang, Xiaoyong
    Liu, Hongyan
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 2009 - 2019
  • [29] Feasibility of the ACL (albumin, C-reactive protein and lactate dehydrogenase) model as a novel prognostic tool in patients with metastatic renal cell carcinoma previously receiving first-line targeted therapy
    Tamura, Keita
    Matsushita, Yuto
    Watanabe, Hiromitsu
    Motoyama, Daisuke
    Ito, Toshiki
    Sugiyama, Takayuki
    Otsuka, Atsushi
    Miyake, Hideaki
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (01) : 6.e9 - 6.e16
  • [30] Outcomes of patients with metastatic clear cell renal cell carcinoma treated with second-line VEGFR-TKI after first-line immune checkpoint inhibitors.
    Shah, Amishi Yogesh
    Kotecha, Ritesh
    Lemke, Emily
    Chandramohan, Anuradha
    Chaim, Joshua
    Msaouel, Pavlos
    Xiao, Lianchun
    Gao, Jianjun
    Campbell, Matthew T.
    Zurita, Amado J.
    Wang, Jennifer
    Corn, Paul Gettys
    Jonasch, Eric
    Motzer, Robert J.
    Sharma, Padmanee
    Voss, Martin Henner
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345